Efficacy of neoadjuvant novel hormonal therapy combined with radical prostatectomy for high-risk prostate cancer and analysis of biochemical recurrence-free survival
American Journal of Translational Research · 2026 · 18 (7) · 5677-5687
DOI: 10.62347/frav7215 ↗At a glance
Journal article in American Journal of Translational Research, 2026. Written by Shaohua Jiang and 5 co-authors. Institution: Department of Urology, Baoji Gaoxin Hospital No. 19, Gaoxin Fourth Road, Baoji 721000, Shaanxi, China. The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Department of Urology, Baoji Gaoxin Hospital No. 19, Gaoxin Fourth Road, Baoji 721000, Shaanxi, China.
- Department of Urology, Xianyang City No. 1 People's Hospital No. 10, Biyuan West Road, Xianyang 712000, Shaanxi, China.
- Department of Urology (Second Ward), China-Japan Union Hospital of Jilin University No. 126, Xiantai Street, Economic Development Zone, Changchun 130033, Jilin, China.
- Department of Urology, The Affiliated Hospital of Northwest University (Xi'an No. 3 Hospital) No. 10, East Section of Fengcheng 3rd Road, Weiyang District, Xi'an 710018, Shaanxi, China.
Cite
APA
Jiang, S., Du, C., Qu, L., Liu, L., Ren, B., & Luo, W. (2026). Efficacy of neoadjuvant novel hormonal therapy combined with radical prostatectomy for high-risk prostate cancer and analysis of biochemical recurrence-free survival. American Journal of Translational Research, 18(7), 5677-5687. https://doi.org/10.62347/frav7215
Vancouver
Jiang S, Du C, Qu L, Liu L, Ren B, Luo W. Efficacy of neoadjuvant novel hormonal therapy combined with radical prostatectomy for high-risk prostate cancer and analysis of biochemical recurrence-free survival. American Journal of Translational Research. 2026;18(7):5677-5687. doi:10.62347/frav7215
BibTeX
@article{Jiang2026,
author = {Jiang, Shaohua and Du, Changguo and Qu, Licheng and Liu, Lei and Ren, Baoming and Luo, Wenshan},
title = {Efficacy of neoadjuvant novel hormonal therapy combined with radical prostatectomy for high-risk prostate cancer and analysis of biochemical recurrence-free survival},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {7},
pages = {5677--5687},
doi = {10.62347/frav7215}
}
EUVIMED